908 Devices director sells 100 shares under plan
908 Devices Inc. director Christopher D. Brown reported an open-market sale of 100 shares of Common Stock at $9.00 per share on June 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
908 Devices Inc. director Christopher D. Brown reported an open-market sale of 100 shares of Common Stock at $9.00 per share on June 4, 2026. After this transaction, he directly holds 875,459 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 24, 2025.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 100 | $9.00 | $900.00 |
Footnotes (1)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
Form 4 regulatory
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did 908 Devices (MASS) report in this Form 4?
What are Christopher D. Brown’s holdings in 908 Devices (MASS) after the reported sale?
Was the 908 Devices (MASS) insider sale made under a Rule 10b5-1 plan?
Who is the insider involved in the recent 908 Devices (MASS) Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.